Evidence map›Paper›PMID 41993687›Full record

ArticleiScience2026

Iturin derived from

Lingyun Zhao, Qing Liu, Jianuo He, Yujian Li, Yang Zhang, Yingxue Feng, Wenya Zhao, Liping Zhang, Yongfeng Liu, Tongliang Li and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lingyun ZhaoInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Qing LiuInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Jianuo HeInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Yujian LiInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Yang ZhangInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Yingxue FengInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Wenya ZhaoInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Liping ZhangInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Yongfeng LiuDepartment of Radiation Oncology, Henan Provincial Key Laboratory of Radiation Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Tongliang LiInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.
Hongwei LiuInstitute of Biology, Hebei Academy of Sciences, Shijiazhuang, Hebei 050011, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD), a metabolic disorder associated with modern dietary patterns, urgently requires safe dietary interventions for prevention. This study explored the bioactivity of iturin (IT), a

Indexed as

hepatology

Identifiers

PMID41993687
PMCPMC13081174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.